HL7 Standards Soon to be Free of Charge

HL7Health Level Seven® International (HL7®), the global leader in developing interoperability standards for healthcare IT, announced its decision to make much of its intellectual property (IP), including standards, freely available under licensing terms. The landmark decision represents HL7's commitment to the betterment of healthcare worldwide by ensuring that all stakeholders have equal access to its HIT standards. The new policy is expected to take effect in the first quarter of 2013.

"HL7's vision is to make its collaborative, consensus-driven standards the best and most widely used in healthcare," said Charles Jaffe, MD, PhD, CEO of HL7. "By eliminating this barrier to implementation, we can come closer to realizing our goal, in which healthcare IT can reduce costs and improve the quality of care. Coupled with increasing government demand for standards that do not require a licensing fee, our decision to move toward free standards is perfectly aligned. To this end, we have already received enthusiastic support for this decision from key healthcare stakeholders."

"This announcement is the most significant standards development in the past decade, said John Halamka, MD, MS, Chief Information Officer of the Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. "It ensures that every stakeholder will have ready access to the content standards they need for Meaningful Use. Enormous thanks to everyone who worked on this effort."

The volunteer-created standards and other select pieces of intellectual property will be made available to the international healthcare community after a period of careful analysis and planning by HL7, expected to take several months. In the interim, the traditional IP/membership model which includes access to, and the right to use HL7 standards, will continue to be in effect. Following completion of the analysis, HL7 expects to transition directly to a model in which use of HL7 standards and select IP is independent of HL7 membership. HL7 will continue to consult with its members to make their investment more valuable, and will seek their input to make this transition seamless and reflective of member needs.

"The IP from HL7 is crucial to achieving interoperability among healthcare providers," said Christopher G. Chute, MD, DrPH, Chair, ISO TC215 on Health Informatics. "It enables efficient and effective care across multidisciplinary teams that increasingly are the norm for healthcare. HL7's decision to make these resources effectively a public good is hugely welcome and will accelerate their value to society and patients everywhere. HL7 now more than ever deserves support and membership from the broader health community to ensure these resource remain state-of-the-art and freely available."

More information on HL7 membership and standards is available at www.hl7.org.

About Health Level Seven (HL7) International
Founded in 1987, Health Level Seven International is the global authority for healthcare Information interoperability and standards with affiliates established in more than 30 countries. HL7 is a nonprofit, ANSI-accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing, and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7's more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare. HL7 collaborates with other standards developers and provider, payer, philanthropic and government agencies at the highest levels to ensure the development of comprehensive and reliable standards and successful interoperability efforts.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...